These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16988450)

  • 1. Surface-modified biodegradable microspheres for DNA vaccine delivery.
    Keegan ME; Saltzman WM
    Methods Mol Med; 2006; 127():107-13. PubMed ID: 16988450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
    Eniola AO; Hammer DA
    Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles for the delivery of DNA vaccines.
    O'Hagan DT; Singh M; Ulmer JB
    Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
    J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors.
    Omolola Eniola A; Hammer DA
    Biomaterials; 2005 Dec; 26(34):7136-44. PubMed ID: 15953632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas foamed open porous biodegradable polymeric microspheres.
    Kim TK; Yoon JJ; Lee DS; Park TG
    Biomaterials; 2006 Jan; 27(2):152-9. PubMed ID: 16023197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation aspects of biodegradable polymeric microspheres for antigen delivery.
    Tamber H; Johansen P; Merkle HP; Gander B
    Adv Drug Deliv Rev; 2005 Jan; 57(3):357-76. PubMed ID: 15560946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA.
    Rouse JJ; Mohamed F; van der Walle CF
    Int J Pharm; 2007 Jul; 339(1-2):112-20. PubMed ID: 17395410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of synthetic biodegradable microparticulate vaccines: a roller coaster story.
    Johansen P; Martínez Gómez JM; Gander B
    Expert Rev Vaccines; 2007 Aug; 6(4):471-4. PubMed ID: 17668999
    [No Abstract]   [Full Text] [Related]  

  • 12. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional nanofibrous scaffolds for bone reconstruction.
    Burger C; Chu B
    Colloids Surf B Biointerfaces; 2007 Apr; 56(1-2):134-41. PubMed ID: 17113762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime.
    Zhou X; Liu B; Yu X; Zha X; Zhang X; Wang X; Jin Y; Wu Y; Chen Y; Shan Y; Chen Y; Liu J; Kong W; Shen J
    Eur J Pharm Biopharm; 2008 Mar; 68(3):589-95. PubMed ID: 17950586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ester-anhydride):poly(beta-amino ester) micro- and nanospheres: DNA encapsulation and cellular transfection.
    Pfeifer BA; Burdick JA; Little SR; Langer R
    Int J Pharm; 2005 Nov; 304(1-2):210-9. PubMed ID: 16174553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
    Gvili K; Benny O; Danino D; Machluf M
    Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
    Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
    Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.
    Kasturi SP; Sachaphibulkij K; Roy K
    Biomaterials; 2005 Nov; 26(32):6375-85. PubMed ID: 15913771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of biodegradable microspheres with surface-bound ligands.
    Keegan ME; Royce SM; Fahmy T; Saltzman WM
    J Control Release; 2006 Feb; 110(3):574-80. PubMed ID: 16386325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.